Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VCYTVERACYTE, INC.

Nasdaq · CIK 0001384101
Filer categoryLarge accelerated filer
Entity typeoperating
SIC8071 Services-Medical Laboratories
FY end1231
XBRL facts424

Identity from submissions API

NameVERACYTE, INC.
CIK0001384101
TickersVCYT
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC8071 Services-Medical Laboratories
EIN205455398
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(650) 243-6300
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • CALDEROME INC (2006-12-06T05:00:00.000Z → 2008-02-27T05:00:00.000Z)
Business address
6000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
CA
Mailing address
6000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1180 filing rows loaded from submissions recent; extra archives: CIK0001384101-submissions-001.json (180 filings, 2006-12-06 to 2015-07-26).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-456858 005-87868 261543007 34 136854
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002866 005-87868 261526327 34 11800
2026-11-05 10-Q 10-Q 0001384101-26-000055 001-36156 261524918 34 7847332 1 1
2026-11-04 8-K 8-K 2.02,8.01,9.01 0001384101-26-000053 001-36156 261522199 34 538695 1 1
2026-10-29 4 FORM 4 0001584145-26-000011 5056
2026-10-28 4 FORM 4 0001819880-26-000006 13573
2026-10-28 4 FORM 4 0001231845-26-000008 8774
2026-10-27 144 xsl144X01/primary_doc.xml 0001950047-26-010439 001-36156 261491000 33 5476
2026-10-27 144 xsl144X01/primary_doc.xml 0001950047-26-010424 001-36156 261490411 33 6464
2026-10-20 4 FORM 4 0001846905-26-000008 4914
2026-09-24 144 xsl144X01/primary_doc.xml 0001950047-26-009791 001-36156 261405057 33 5703
2026-09-22 4 FORM 4 0001991536-26-000013 4979
2026-09-21 144 xsl144X01/primary_doc.xml 0001950047-26-009711 001-36156 261394329 33 4877
2026-09-16 4 FORM 4 0001819880-26-000004 5255
2026-09-14 144 xsl144X01/primary_doc.xml 0001950047-26-009444 001-36156 261378121 33 5534
2026-09-14 8-K 8-K 1.01,2.01,7.01,9.01 0001384101-26-000049 001-36156 261377408 34 42875507 1 1
2026-09-04 4 FORM 4 0001584145-26-000009 5260
2026-09-04 4 FORM 4 0001991536-26-000011 5083
2026-09-04 4 FORM 4 0001649245-26-000009 8740
2026-09-04 4 FORM 4 0001823563-26-000016 8727
2026-09-04 4 FORM 4 0001914620-26-000013 8925
2026-09-04 4 FORM 4 0001539796-26-000019 5284
2026-09-04 144 xsl144X01/primary_doc.xml 0001950047-26-009146 001-36156 261362494 33 4882
2026-09-04 144 xsl144X01/primary_doc.xml 0001950047-26-009145 001-36156 261362489 33 4898
2026-09-04 144 xsl144X01/primary_doc.xml 0001950047-26-009139 001-36156 261362401 33 5049
2026-09-03 4 FORM 4 0001846905-26-000006 4914
2026-09-01 144 xsl144X01/primary_doc.xml 0001950047-26-008941 001-36156 261351392 33 4881
2026-07-31 10-Q 10-Q 0001384101-26-000044 001-36156 261228665 34 6887934 1 1
2026-07-30 8-K 8-K 2.02,9.01 0001384101-26-000042 001-36156 261223565 34 524245 1 1
2026-06-22 4 FORM 4 0001231845-26-000006 6995
2026-06-18 144 xsl144X01/primary_doc.xml 0001950047-26-006311 001-36156 261103009 33 4890
2026-06-15 4 FORM 4 0001231845-26-000004 5094
2026-06-15 4 FORM 4 0001020741-26-000002 5260
2026-06-15 4 FORM 4 0001728374-26-000004 5052
2026-06-15 4 FORM 4 0001940521-26-000002 5088
2026-06-15 4 FORM 4 0001252004-26-000004 5100
2026-06-15 4 FORM 4 0001819880-26-000002 5094
2026-06-15 4 FORM 4 0001846905-26-000002 5091
2026-06-15 4 FORM 4 0002034921-26-000002 5100
2026-06-11 8-K 8-K 5.02,5.07 0001384101-26-000038 001-36156 261083603 34 382875 1 1
2026-06-10 S-8 S-8 0001384101-26-000036 333-296673 261079888 33 223464 1 1
2026-06-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001411 005-87868 261067319 34 11754
2026-06-04 4 FORM 4 0001914620-26-000011 8717
2026-06-04 4 FORM 4 0001584145-26-000007 5052
2026-06-04 4 FORM 4 0001823563-26-000014 8723
2026-06-04 4 FORM 4 0001649245-26-000007 5097
2026-06-04 4 FORM 4 0001539796-26-000015 11004
2026-06-04 4 FORM 4 0001991536-26-000009 6976
2026-06-04 144 xsl144X01/primary_doc.xml 0001950047-26-005662 001-36156 261065516 33 5612
2026-06-04 144 xsl144X01/primary_doc.xml 0001950047-26-005656 001-36156 261065488 33 5039
2026-06-04 144 xsl144X01/primary_doc.xml 0001950047-26-005655 001-36156 261065482 33 5191
2026-06-04 144 xsl144X01/primary_doc.xml 0001950047-26-005651 001-36156 261065454 33 4892
2026-05-27 4 FORM 4 0001584145-26-000006 8536
2026-05-22 4 FORM 4 0001252004-26-000002 5265
2026-05-20 144 xsl144X01/primary_doc.xml 0001950047-26-004846 001-36156 261004651 33 4907
2026-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-220565 005-87868 26970855 34 138367
2026-05-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000310 005-87868 26967137 34 8200
2026-05-08 4 FORM 4 0001914620-26-000010 6383
2026-05-06 144 xsl144X01/primary_doc.xml 0001950047-26-004132 001-36156 26948900 33 5613
2026-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001331 005-87868 26946994 34 11381
2026-05-06 10-Q 10-Q 0001384101-26-000031 001-36156 26945901 34 6567527 1 1
2026-05-05 8-K 8-K 2.02,9.01 0001384101-26-000029 001-36156 26943106 34 415067 1 1
2026-04-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001243 005-87868 26923588 34 7514
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-000825 005-87868 26915442 34 7459
2026-04-22 ARS ARS 0001384101-26-000023 001-36156 26883873 34 2742744
2026-04-22 DEFA14A DEFA14A 0001384101-26-000022 001-36156 26883830 34 282390
2026-04-22 DEF 14A DEF 14A 0001384101-26-000021 001-36156 26883791 34 181966193 1 1
2026-04-14 4 FORM 4 0001843872-26-000011 5042
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002549 005-87868 26805123 34 7280
2026-03-25 3 FORM 3 0001843872-26-000009 10786
2026-03-16 8-K 8-K 5.02 0001384101-26-000012 001-36156 26756925 34 146622 1 1
2026-03-10 4 FORM 4 0001584145-26-000004 4894
2026-03-10 4 FORM 4 0001914620-26-000008 6525
2026-03-10 4 FORM 4 0001649245-26-000006 6545
2026-03-10 4 FORM 4 0001991536-26-000008 6527
2026-03-10 4 FORM 4 0001539796-26-000012 4902
2026-03-10 4 FORM 4 0001823563-26-000008 6532
2026-03-06 4 FORM 4 0001823563-26-000006 6929
2026-03-06 4 FORM 4 0001539796-26-000010 6926
2026-03-06 4 FORM 4 0001991536-26-000006 5182
2026-03-06 4 FORM 4 0001914620-26-000006 6921
2026-03-04 144 xsl144X01/primary_doc.xml 0001950047-26-002196 001-36156 26722197 33 5609
2026-03-04 144 xsl144X01/primary_doc.xml 0001950047-26-002194 001-36156 26722186 33 4875
2026-03-04 144 xsl144X01/primary_doc.xml 0001950047-26-002187 001-36156 26722129 33 5059
2026-03-04 144 xsl144X01/primary_doc.xml 0001950047-26-002179 001-36156 26722052 33 6255
2026-03-04 4 FORM 4 0001914620-26-000004 4940
2026-03-04 4 FORM 4 0001584145-26-000002 5136
2026-03-04 4 FORM 4 0001823563-26-000004 4946
2026-03-04 4 FORM 4 0001991536-26-000004 4942
2026-03-04 4 FORM 4 0001649245-26-000004 6862
2026-03-04 4 FORM 4 0001539796-26-000008 4940
2026-03-02 4 FORM 4 0001991536-26-000002 6830
2026-03-02 4 FORM 4 0001539796-26-000006 7046
2026-03-02 4 FORM 4 0001823563-26-000002 6840
2026-03-02 4 FORM 4 0001649245-26-000002 6854
2026-03-02 4 FORM 4 0001914620-26-000002 7040
2026-03-02 144 xsl144X01/primary_doc.xml 0001950047-26-002015 001-36156 26708449 33 4888
2026-02-26 10-K 10-K 0001384101-26-000010 001-36156 26689445 34 11493298 1 1
2026-02-25 8-K 8-K 2.02,9.01 0001384101-26-000008 001-36156 26678553 34 533756 1 1
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000563 005-87868 26602084 34 11672
2026-02-03 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-035096 005-87868 26591783 34 137543
2026-01-12 8-K 8-K 2.02,9.01 0001384101-26-000002 001-36156 26524534 34 186907 1 1
2026-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-001972 005-87868 26517738 34 13299
2025-12-17 4 FORM 4 0001914620-25-000012 6585
2025-12-16 144 xsl144X01/primary_doc.xml 0001950047-25-010407 001-36156 251575832 33 7956
2025-12-08 4 FORM 4 0001231845-25-000007 15552
2025-12-05 144 xsl144X01/primary_doc.xml 0001950047-25-009854 001-36156 251553288 33 5625
2025-12-04 4 FORM 4 0001649245-25-000007 4963
2025-12-04 4 FORM 4 0001914620-25-000010 8244
2025-12-04 4 FORM 4 0001823563-25-000007 8589
2025-12-04 4 FORM 4 0001539796-25-000005 8586
2025-12-04 4 FORM 4 0001991536-25-000008 6504
2025-12-04 4 FORM 4 0001584145-25-000010 4934
2025-12-04 144 xsl144X01/primary_doc.xml 0001950047-25-009790 001-36156 251550278 33 7066
2025-12-04 144 xsl144X01/primary_doc.xml 0001950047-25-009788 001-36156 251550270 33 5793
2025-12-04 144 xsl144X01/primary_doc.xml 0001950047-25-009787 001-36156 251550265 33 4953
2025-11-26 4 FORM 4 0001991536-25-000006 4843
2025-11-26 4 FORM 4 0001020741-25-000006 5290
2025-11-25 144 xsl144X01/primary_doc.xml 0001958244-25-004481 001-36156 251523361 33 6449
2025-11-25 144 xsl144X01/primary_doc.xml 0001950047-25-009361 001-36156 251521689 33 5763
2025-11-21 4 FORM 4 0001819880-25-000005 8597
2025-11-20 144 xsl144X01/primary_doc.xml 0001950047-25-009123 001-36156 251503044 33 5536
2025-11-12 4 FORM 4 0001584145-25-000008 6680
2025-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-275701 005-87868 251468373 34 135219
2025-11-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-25-000644 005-87868 251464716 34 8109
2025-11-07 4 FORM 4 0001914620-25-000008 4846
2025-11-07 4 FORM 4 0001020741-25-000004 24381
2025-11-07 4 FORM 4 0001231845-25-000005 5119
2025-11-07 4 FORM 4 0001823563-25-000005 4851
2025-11-05 144 xsl144X01/primary_doc.xml 0001958244-25-004439 001-36156 251455875 33 7809
2025-11-05 144 xsl144X01/primary_doc.xml 0001950047-25-008483 001-36156 251454336 33 4885
2025-11-05 144 xsl144X01/primary_doc.xml 0001950047-25-008481 001-36156 251454316 33 6337
2025-11-05 144 xsl144X01/primary_doc.xml 0001950047-25-008479 001-36156 251454300 33 5056
2025-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002838 005-87868 251452790 34 11674
2025-11-05 10-Q 10-Q 0001384101-25-000130 001-36156 251451908 34 6999286 1 1
2025-11-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-106410 005-87868 251450640 34 13348
2025-11-04 8-K 8-K 2.02,9.01 0001384101-25-000128 001-36156 251449015 34 526781 1 1
2025-10-30 4 FORM 4 0001584145-25-000006 4874
2025-10-07 4 FORM 4 0001649245-25-000005 5206
2025-10-06 144 xsl144X01/primary_doc.xml 0001950047-25-007776 001-36156 251377058 33 5051
2025-10-03 4 FORM 4 0001991536-25-000004 4843
2025-10-03 4 FORM 4 0001252004-25-000005 8576
2025-10-03 4 FORM 4 0001914620-25-000006 5186
2025-10-01 144 xsl144X01/primary_doc.xml 0001950047-25-007631 001-36156 251364957 33 5485
2025-10-01 144 xsl144X01/primary_doc.xml 0001950047-25-007630 001-36156 251364954 33 4874
2025-10-01 144 xsl144X01/primary_doc.xml 0001950047-25-007626 001-36156 251364938 33 5771
2025-09-23 4 FORM 4 0001914620-25-000004 5186
2025-09-19 144 xsl144X01/primary_doc.xml 0001950047-25-007368 001-36156 251327156 33 5042
2025-09-08 4 FORM 4 0001384101-25-000124 5187
2025-09-04 4 FORM 4 0001384101-25-000122 4951
2025-09-04 4 FORM 4 0001384101-25-000120 5147
2025-09-04 4 FORM 4 0001384101-25-000118 5147
2025-09-04 4 FORM 4 0001384101-25-000116 4965
2025-09-04 4 FORM 4 0001384101-25-000114 4946
2025-09-04 4 FORM 4 0001384101-25-000112 5138
2025-09-04 144 xsl144X01/primary_doc.xml 0001950047-25-006751 001-36156 251293755 33 4951
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000316 005-87868 251204885 34 15438
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-178383 005-87868 251203874 34 141040
2025-08-07 10-Q 10-Q 0001384101-25-000110 001-36156 251194878 34 6520859 1 1
2025-08-06 8-K 8-K 2.02,9.01 0001384101-25-000106 001-36156 251189589 34 523705 1 1
2025-08-01 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003375 005-87868 251175565 34 11230
2025-06-23 4 FORM 4 0001384101-25-000099 4957
2025-06-23 4 FORM 4 0001384101-25-000098 4957
2025-06-23 4 FORM 4 0001384101-25-000097 5123
2025-06-23 4 FORM 4 0001384101-25-000096 4963
2025-06-23 4 FORM 4 0001384101-25-000095 4951
2025-06-23 4 FORM 4 0001384101-25-000094 4954
2025-06-23 4 FORM 4 0001384101-25-000093 4963
2025-06-23 4 FORM 4 0001384101-25-000092 4915
2025-06-18 8-K 8-K 5.02,5.07,9.01 0001384101-25-000083 001-36156 251057537 34 411162 1 1
2025-06-17 S-8 S-8 0001384101-25-000081 333-288113 251053852 33 220873 1 1
2025-06-17 4 FORM 4 0001384101-25-000080 5118
2025-06-17 4 FORM 4 0001384101-25-000079 5119
2025-06-13 144 xsl144X01/primary_doc.xml 0001950047-25-004290 001-36156 251047330 33 4887
2025-06-13 144 xsl144X01/primary_doc.xml 0001950047-25-004288 001-36156 251047324 33 4883
2025-06-06 4 FORM 4 0001384101-25-000074 5187
2025-06-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-057245 005-87868 251030172 34 13529
2025-06-04 4 FORM 4 0001384101-25-000072 5117
2025-06-04 4 FORM 4 0001384101-25-000071 5152
2025-06-04 4 FORM 4 0001384101-25-000070 5107
2025-06-04 4 FORM 4 0001384101-25-000069 5102
2025-06-04 4 FORM 4 0001384101-25-000068 5100
2025-06-04 4 FORM 4 0001384101-25-000067 5119
2025-06-04 144 xsl144X01/primary_doc.xml 0001950047-25-003817 001-36156 251023378 33 5604
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-071972 005-87868 25948663 34 105888
2025-05-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-048308 005-87868 25943355 34 13433
2025-05-08 10-Q 10-Q 0001384101-25-000060 001-36156 25923988 34 5755801 1 1
2025-05-07 8-K 8-K 2.02,9.01 0001384101-25-000058 001-36156 25921362 34 449316 1 1
2025-05-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-045413 005-87868 25920119 34 6887
2025-05-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001110 005-87868 25919915 34 11667
2025-05-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001101 005-87868 25919862 34 11488
2025-04-29 ARS ARS 0001384101-25-000053 001-36156 25888455 34 3311707
2025-04-29 DEFA14A DEFA14A 0001384101-25-000052 001-36156 25888412 34 286564
2025-04-29 DEF 14A DEF 14A 0001384101-25-000051 001-36156 25888365 34 36940069 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000667 005-87868 25844615 34 11133
2025-03-10 4 FORM 4 0001384101-25-000045 4901
2025-03-10 4 FORM 4 0001384101-25-000044 4931
2025-03-10 4 FORM 4 0001384101-25-000043 4917
2025-03-10 4 FORM 4 0001384101-25-000042 8553
2025-03-10 4 FORM 4 0001384101-25-000041 4910
2025-03-10 4 FORM 4 0001384101-25-000040 4909
2025-03-07 144 xsl144X01/primary_doc.xml 0001950047-25-001654 001-36156 25720311 33 4861
2025-03-06 4 FORM 4 0001384101-25-000032 6937
2025-03-06 4 FORM 4 0001384101-25-000031 8622
2025-03-06 4 FORM 4 0001384101-25-000030 5191
2025-03-04 144 xsl144X01/primary_doc.xml 0001950047-25-001535 001-36156 25706254 33 4887
2025-03-04 144 xsl144X01/primary_doc.xml 0001950047-25-001503 001-36156 25706111 33 6225
2025-03-04 144 xsl144X01/primary_doc.xml 0001950047-25-001500 001-36156 25706096 33 5463
2025-03-03 4 FORM 4 0001384101-25-000026 8445
2025-03-03 4 FORM 4 0001384101-25-000025 8638
2025-03-03 4 FORM 4 0001384101-25-000024 8445
2025-03-03 4 FORM 4 0001384101-25-000023 5245
2025-03-03 4 FORM 4 0001384101-25-000022 8455
2025-03-03 4 FORM 4 0001384101-25-000021 8681
2025-02-28 10-K 10-K 0001384101-25-000014 001-36156 25682264 34 11256761 1 1
2025-02-24 8-K 8-K 2.02,9.01 0001384101-25-000010 001-36156 25657098 34 542867 1 1
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-018322 005-87868 25611745 34 26356
2025-02-05 4 FORM 4 0001384101-25-000006 4801
2025-01-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-002716 005-87868 25524518 34 7200
2025-01-08 4 FORM 4 0001384101-25-000004 6516
2025-01-06 4 FORM 4 0001384101-25-000002 10382
2025-01-02 144 xsl144X01/primary_doc.xml 0001950047-25-000044 001-36156 25502336 33 5637
2024-12-17 4 FORM 4 0001384101-24-000188 6882
2024-12-13 144 xsl144X01/primary_doc.xml 0001950047-24-009802 001-36156 241548785 33 4910
2024-12-06 4 FORM 4 0001384101-24-000186 5200
2024-12-06 4 FORM 4 0001384101-24-000185 5194
2024-12-05 144 xsl144X01/primary_doc.xml 0001950047-24-009489 001-36156 241529952 33 5739
2024-12-04 4 FORM 4 0001384101-24-000182 5094
2024-12-04 4 FORM 4 0001384101-24-000181 6961
2024-12-04 4 FORM 4 0001384101-24-000180 6974
2024-12-04 4 FORM 4 0001384101-24-000179 5026
2024-12-04 4 FORM 4 0001384101-24-000178 6398
2024-12-04 4 FORM 4 0001384101-24-000177 5046
2024-12-04 144 xsl144X01/primary_doc.xml 0001950047-24-009428 001-36156 241526685 33 4887
2024-12-04 144 xsl144X01/primary_doc.xml 0001950047-24-009416 001-36156 241526652 33 5052
2024-12-03 144 xsl144X01/primary_doc.xml 0001950047-24-009372 001-36156 241523245 33 6330
2024-12-03 144 xsl144X01/primary_doc.xml 0001950047-24-009370 001-36156 241523240 33 5591
2024-11-29 4 FORM 4 0001384101-24-000170 4935
2024-11-21 4 FORM 4 0001384101-24-000168 8609
2024-11-19 144 xsl144X01/primary_doc.xml 0001950047-24-008798 001-36156 241476462 33 4900
2024-11-14 4 FORM 4 0001384101-24-000166 5141
2024-11-14 4 FORM 4 0001384101-24-000165 8496
2024-11-12 144 xsl144X01/primary_doc.xml 0001950047-24-008470 001-36156 241448792 33 4753
2024-11-12 144 xsl144X01/primary_doc.xml 0001950047-24-008468 001-36156 241448779 33 6186
2024-11-12 SC 13G SC 13G 0001193125-24-255283 005-87868 241444183 34 95033
2024-11-08 SC 13G/A SEC SCHEDULE 13G 0000902219-24-000417 005-87868 241438559 34 36177
2024-11-07 10-Q 10-Q 0001384101-24-000162 001-36156 241433278 34 6838832 1 1
2024-11-06 8-K 8-K 2.02,9.01 0001384101-24-000160 001-36156 241431039 34 520293 1 1
2024-10-02 SC 13G/A UnitedStates_13G__VeracyteIn.txt 0000932471-24-000163 005-87868 241346460 34 6693
2024-09-23 4 FORM 4 0001384101-24-000155 6133
2024-09-06 4 FORM 4 0001384101-24-000153 5171
2024-09-04 4 FORM 4 0001384101-24-000151 5073
2024-09-04 4 FORM 4 0001384101-24-000150 5094
2024-09-04 4 FORM 4 0001384101-24-000148 5220
2024-09-04 4 FORM 4 0001384101-24-000147 5232
2024-09-04 4 FORM 4 0001384101-24-000146 5063
2024-09-04 4 FORM 4 0001384101-24-000141 5044
2024-09-04 4 FORM 4 0001384101-24-000140 5005
2024-09-04 144 xsl144X01/primary_doc.xml 0001950047-24-006792 001-36156 241277832 33 5595
2024-09-04 3 FORM 3 0001384101-24-000137 11199
2024-09-04 3 FORM 3 0001384101-24-000136 11005
2024-09-04 8-K 8-K 5.02 0001384101-24-000133 001-36156 241277653 34 154702 1 1
2024-08-14 4 FORM 4 0001384101-24-000128 20580
2024-08-13 4 FORM 4 0001384101-24-000126 10522
2024-08-13 4/A FORM 4/A 0001384101-24-000125 7459
2024-08-09 4 FORM 4 0001384101-24-000122 6184
2024-08-09 4 FORM 4 0001384101-24-000121 9658
2024-08-07 144 xsl144X01/primary_doc.xml 0001958244-24-003909 001-36156 241185566 33 7100
2024-08-07 10-Q 10-Q 0001384101-24-000118 001-36156 241181534 34 6455425 1 1
2024-08-06 8-K 8-K 2.02,9.01 0001384101-24-000116 001-36156 241179497 34 483958 1 1
2024-07-18 4 FORM 4 0001384101-24-000111 4791
2024-07-18 4 FORM 4 0001384101-24-000110 4832
2024-07-18 4 FORM 4 0001384101-24-000109 6184
2024-07-16 144 xsl144X01/primary_doc.xml 0001950047-24-005467 001-36156 241120022 33 4864
2024-07-16 144 xsl144X01/primary_doc.xml 0001950047-24-005429 001-36156 241119677 33 6467
2024-07-08 SC 13G/A us92337f1075_070824.txt 0001086364-24-008180 005-87868 241105182 34 14107
2024-06-17 4 FORM 4 0001384101-24-000105 5971
2024-06-17 4 FORM 4 0001384101-24-000104 4959
2024-06-17 4 FORM 4 0001384101-24-000103 4956
2024-06-17 4 FORM 4 0001384101-24-000102 4962
2024-06-17 4 FORM 4 0001384101-24-000101 4818
2024-06-17 4 FORM 4 0001384101-24-000100 4971
2024-06-13 8-K 8-K 5.02,5.07,9.01 0001384101-24-000093 001-36156 241041614 34 406598 1 1
2024-06-13 4 FORM 4 0001384101-24-000091 4794
2024-06-13 UPLOAD filename1.pdf 0000000000-24-006797 001-36156 39810
2024-06-12 S-8 S-8 0001384101-24-000088 333-280150 241039081 33 223074
2024-06-11 144 xsl144X01/primary_doc.xml 0001950047-24-004628 001-36156 241036422 33 6473
2024-06-11 4 FORM 4 0001384101-24-000086 5126
2024-06-11 4 FORM 4 0001384101-24-000085 8308
2024-06-07 144 xsl144X01/primary_doc.xml 0001950047-24-004532 001-36156 241030297 33 5708
2024-06-07 CORRESP filename1.htm 0001384101-24-000081 131607
2024-06-04 4 FORM 4 0001384101-24-000079 5073
2024-06-04 4 FORM 4 0001384101-24-000078 5094
2024-06-04 4 FORM 4 0001384101-24-000077 5046
2024-06-04 4 FORM 4 0001384101-24-000076 5063
2024-06-04 4 FORM 4 0001384101-24-000075 5034
2024-05-30 4 FORM 4 0001384101-24-000069 4784
2024-05-28 144 xsl144X01/primary_doc.xml 0001950047-24-004164 001-36156 24992252 33 5053
2024-05-28 UPLOAD filename1.pdf 0000000000-24-006108 001-36156 46932
2024-05-08 10-Q 10-Q 0001384101-24-000067 001-36156 24927329 34 5802315 1 1
2024-05-07 8-K 8-K 2.02,9.01 0001384101-24-000064 001-36156 24921920 34 407034 1 1
2024-04-25 ARS ARS 0001384101-24-000059 001-36156 24877029 34 2966962
2024-04-25 DEFA14A DEFA14A 0001384101-24-000058 001-36156 24876998 34 199228
2024-04-25 DEF 14A DEF 14A 0001384101-24-000057 001-36156 24876951 34 3773474 1 1
2024-04-17 8-K/A 8-K/A 9.01 0001384101-24-000051 001-36156 24851564 34 978641 1 1
2024-04-02 4 FORM 4 0001384101-24-000047 8653
2024-04-01 144 xsl144X01/primary_doc.xml 0001950047-24-002860 001-36156 24811754 33 4948
2024-03-22 8-K 8-K 8.01,9.01 0001193125-24-075385 001-36156 24775938 34 169140 1 1
2024-03-22 424B7 424B7 0001193125-24-075374 333-277529 24775912 33 382838
2024-03-19 4 FORM 4 0001384101-24-000045 6757
2024-03-19 4 FORM 4 0001384101-24-000044 6759
2024-03-08 4 FORM 4 0001384101-24-000041 4860
2024-03-08 4 FORM 4 0001384101-24-000040 4892
2024-03-08 4 FORM 4 0001384101-24-000039 4909
2024-03-08 4 FORM 4 0001384101-24-000038 4850
2024-03-08 4 FORM 4 0001384101-24-000037 4859
2024-03-08 4 FORM 4 0001384101-24-000036 4917
2024-03-05 4 FORM 4 0001384101-24-000029 5092
2024-03-05 4 FORM 4 0001384101-24-000028 5220
2024-03-05 4 FORM 4 0001384101-24-000027 9375
2024-03-05 4 FORM 4 0001384101-24-000026 5070
2024-03-05 4 FORM 4 0001384101-24-000025 5063
2024-03-05 4 FORM 4 0001384101-24-000024 5230
2024-03-01 144 xsl144X01/primary_doc.xml 0001972362-24-000283 001-36156 24712433 33 4505
2024-02-29 8-K 8-K 8.01,9.01 0001193125-24-053689 001-36156 24705289 34 181477 1 1
2024-02-29 424B7 424B7 0001193125-24-053668 333-277529 24705206 33 415430
2024-02-29 S-8 S-8 0001193125-24-053662 333-277552 24705193 33 124955
2024-02-29 S-3ASR S-3ASR 0001193125-24-053516 333-277529 24704505 33 712353
2024-02-29 10-K 10-K 0001384101-24-000017 001-36156 24698984 34 10283741 1 1
2024-02-22 8-K 8-K 2.02,9.01 0001384101-24-000013 001-36156 24664862 34 491009 1 1
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-022220 005-87868 24629786 34 13140
2024-02-13 8-K 8-K 5.02 0001384101-24-000007 001-36156 24626092 34 153844 1 1
2024-02-12 SC 13G/A SC 13G/A 0001193125-24-030897 005-87868 24617244 34 92501
2024-02-08 SC 13G/A SEC SCHEDULE 13G 0000902219-24-000138 005-87868 24607349 34 37799
2024-02-06 8-K 8-K 2.01,3.02 0001384101-24-000004 001-36156 24598155 34 159635 1 1
2024-01-29 SC 13G/A SC 13G/A 0001104659-24-007698 005-87868 24573556 34 48574
2024-01-24 SC 13G/A us92337f1075_012424.txt 0001086364-24-002741 005-87868 24557814 34 13727
2024-01-22 SC 13G/A Veracyte_Inc.txt 0000093751-24-000069 005-87868 24548069 34 8609
2024-01-08 8-K 8-K 2.02,7.01,9.01 0001193125-24-003949 001-36156 24518454 34 189593 1 1
2023-12-05 4 FORM 4 0001384101-23-000173 4961
2023-12-05 4 FORM 4 0001384101-23-000172 4900
2023-12-05 4 FORM 4 0001384101-23-000171 4912
2023-12-05 4 FORM 4 0001384101-23-000170 4896
2023-12-05 4 FORM 4 0001384101-23-000169 4936
2023-11-08 10-Q 10-Q 0001384101-23-000163 001-36156 231386117 34 5445301 1 1
2023-11-07 8-K 8-K 2.02,9.01 0001384101-23-000161 001-36156 231383784 34 487651 1 1
2023-10-04 4 FORM 4 0001384101-23-000155 7098
2023-10-04 3 FORM 3 0001384101-23-000153 10413
2023-09-06 4 FORM 4 0001384101-23-000150 4966
2023-09-06 4 FORM 4 0001384101-23-000149 5098
2023-09-06 4 FORM 4 0001384101-23-000148 5089
2023-09-06 4 FORM 4 0001384101-23-000147 5124
2023-09-06 4 FORM 4 0001384101-23-000146 4898
2023-09-06 3 FORM 3 0001384101-23-000145 13823
2023-08-09 10-Q 10-Q 0001384101-23-000142 001-36156 231155154 34 5623996 1 1
2023-08-08 8-K 8-K 2.02,5.02,9.01 0001384101-23-000140 001-36156 231151409 34 480198 1 1
2023-07-24 4 FORM 4 0001384101-23-000134 7367
2023-07-19 4 FORM 4 0001384101-23-000132 13238
2023-07-19 4 FORM 4 0001384101-23-000130 11025
2023-07-19 144 xsl144X01/primary_doc.xml 0001958244-23-001300 001-36156 231097284 33 8885
2023-07-19 144 xsl144X01/primary_doc.xml 0001958244-23-001299 001-36156 231097219 33 8838
2023-07-18 144 xsl144X01/primary_doc.xml 0001958244-23-001297 001-36156 231095080 33 7227
2023-07-18 144 xsl144X01/primary_doc.xml 0001958244-23-001296 001-36156 231095061 33 7179
2023-07-17 144 xsl144X01/primary_doc.xml 0001958244-23-001293 001-36156 231092337 33 5557
2023-07-17 144 xsl144X01/primary_doc.xml 0001958244-23-001292 001-36156 231092321 33 6213
2023-07-10 144 xsl144X01/primary_doc.xml 0001950047-23-002207 001-36156 231079889 33 6988
2023-06-21 4 FORM 4 0001384101-23-000128 6422
2023-06-15 144 xsl144X01/primary_doc.xml 0001950047-23-001653 001-36156 231017418 33 5531
2023-06-13 4 FORM 4 0001384101-23-000126 4788
2023-06-13 4 FORM 4 0001384101-23-000125 4947
2023-06-13 4 FORM 4 0001384101-23-000124 5947
2023-06-13 4 FORM 4 0001384101-23-000123 4932
2023-06-13 4 FORM 4 0001384101-23-000122 4938
2023-06-13 4 FORM 4 0001384101-23-000121 4794
2023-06-13 4 FORM 4 0001384101-23-000120 4935
2023-06-09 8-K 8-K 5.02,5.03,5.07 0001384101-23-000112 001-36156 231006167 34 1206444 1 1
2023-06-09 SC 13G/A SEC SCHEDULE 13G 0000902219-23-000031 005-87868 231004128 34 37686
2023-06-08 S-8 POS S-8 POS 0001384101-23-000109 333-191992 231002724 33 694491
2023-06-08 S-8 POS S-8 POS 0001384101-23-000108 333-203097 231002714 33 694491
2023-06-08 S-8 POS S-8 POS 0001384101-23-000107 333-210185 231002712 33 694491
2023-06-08 S-8 POS S-8 POS 0001384101-23-000106 333-216388 231002706 33 694491
2023-06-08 S-8 POS S-8 POS 0001384101-23-000105 333-223292 231002698 33 694491
2023-06-08 S-8 POS S-8 POS 0001384101-23-000104 333-229848 231002685 33 694491
2023-06-08 S-8 POS S-8 POS 0001384101-23-000103 333-236630 231002676 33 694491
2023-06-08 S-8 POS S-8 POS 0001384101-23-000102 333-253363 231002672 33 694593
2023-06-08 S-8 POS S-8 POS 0001384101-23-000101 333-263116 231002667 33 694491
2023-06-08 S-8 POS S-8 POS 0001384101-23-000100 333-270147 231002643 33 694491
2023-06-06 4 FORM 4 0001384101-23-000083 4890
2023-06-06 4 FORM 4 0001384101-23-000082 4948
2023-06-06 4 FORM 4 0001384101-23-000081 4952
2023-06-06 4 FORM 4 0001384101-23-000080 5702
2023-06-06 4 FORM 4 0001384101-23-000079 4951
2023-06-01 4 FORM 4 0001384101-23-000072 4767
2023-06-01 DEFA14A DEFA14A CLAWBACK POLICY 0001384101-23-000070 001-36156 23983133 34 17738
2023-05-30 144 xsl144X01/primary_doc.xml 0001950047-23-001056 001-36156 23977527 33 4955
2023-05-05 10-Q 10-Q 0001384101-23-000067 001-36156 23891371 34 5382653 1 1
2023-05-04 8-K 8-K 2.02,9.01 0001384101-23-000065 001-36156 23888880 34 423229 1 1
2023-04-27 ARS ARS 0001384101-23-000059 001-36156 23857760 34 3605111
2023-04-27 DEFA14A DEFA14A 0001384101-23-000057 001-36156 23857698 34 261793
2023-04-27 DEF 14A DEF 14A 0001384101-23-000055 001-36156 23857657 34 4318443 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (424 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 80.70M 2026-10-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
dei EntityPublicFloat Entity Public Float USD 1.70B 2025-06-30 2025 FY 10-K 2026-02-26 0001384101-26-000010
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 517.10M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001384101-26-000021
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 3.71M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001384101-26-000021
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.84M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001384101-26-000021
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001384101-26-000021
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 9.61M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001384101-26-000021
ecd PeoTotalCompAmt PeoTotalCompAmt USD 7.42M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001384101-26-000021
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 86.02 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001384101-26-000021
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 9.71M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 56.79M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 2.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 2.10M 2015-12-31 2015 FY 10-K 2016-03-14 0001047469-16-011115
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 60.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap AccruedMarketingCostsCurrent Accrued Marketing Costs, Current USD 0 2016-12-31 2016 FY 10-K 2017-03-01 0001384101-17-000008
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 62,000 2013-12-31 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 25.98M 2022-12-31 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -8.06M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.73B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap AdjustmentForAmortization Amortization USD 1.40M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-25 0001384101-20-000015
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 17.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD 728,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-02 0001437749-20-022261
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 38.68M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-29 0001384101-24-000017
us-gaap AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net USD -810,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-10-22 0001384101-19-000132
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 43.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 131,000 2016-03-31 2016 Q1 10-Q 2016-05-05 0001104659-16-118328
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 52,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-05 0001104659-16-118328
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001384101-21-000012
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001384101-22-000028
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 10.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 172,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap Assets Assets USD 1.57B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap AssetsCurrent Assets, Current USD 467.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 200.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -29.09M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-01 0001384101-17-000008
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 38.19M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-01 0001384101-17-000008
us-gaap BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable Business Combination, Consideration Transferred, Equity Interests Issued and Issuable USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001384101-21-000012
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD -1.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 23.98M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 6.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 17.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 2.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 0 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 317,000 2018-09-30 2018 Q3 10-Q 2018-10-29 0001384101-18-000078
us-gaap CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear Capital Leases, Future Minimum Payments, Remainder of Fiscal Year USD 79,000 2018-09-30 2018 Q3 10-Q 2018-10-29 0001384101-18-000078
us-gaap CapitalLeasesIncomeStatementInterestExpense Capital Leases, Income Statement, Interest Expense USD 33,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-07 0001384101-17-000068
us-gaap CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation USD 367,000 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 199.83M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 26.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 289.40M 2024-12-31 2024 FY 10-K 2025-02-28 0001384101-25-000014
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 201.47M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -162.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -162.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 24,801 2013-12-31 2014 Q3 10-Q 2014-11-13 0001104659-14-080432
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 18.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 125.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 80.66M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 80.66M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap CommonStockValue Common Stock, Value, Issued USD 81,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 85.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 864,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 79.02M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001047469-16-011115
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 59.99M 2013-11-02 2013-11-04 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 0.25 2013-10-09 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap CostDirectMaterial Cost, Direct Material USD 446,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-25 0001384101-20-000015
us-gaap CostOfGoodsAndServicesSoldAmortization Cost, Amortization USD 8.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap CostOfRevenue Cost of Revenue USD 8.51M 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-06 0001384101-20-000058
us-gaap CostsAndExpenses Costs and Expenses USD 254.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 114,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 2.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 2.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 5.00M 2013-06-30 2014 Q3 10-Q 2014-11-13 0001104659-14-080432
us-gaap DebtInstrumentIncreaseDecreaseForPeriodNet Debt Instrument, Increase (Decrease), Net USD 5.00M 2013-06-01 2013-06-30 2016 FY 10-K 2017-03-01 0001384101-17-000008
us-gaap DebtSecuritiesHeldToMaturityAllowanceForCreditLoss Debt Securities, Held-to-maturity, Allowance for Credit Loss USD 0 2022-12-31 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss USD 24.61M 2022-12-31 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss USD 170.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap DebtSecuritiesHeldToMaturitySoldAmount Debt Securities, Held-to-maturity, Sold, Amount USD 39.80M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DebtSecuritiesUnrealizedGainLoss Debt Securities, Unrealized Gain (Loss) USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeconsolidationGainOrLossAmount Deconsolidation, Gain (Loss), Amount USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -307,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 32,000 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -580,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 31.84M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 1.62M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 86,000 2013-12-31 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2019-09-30 2019 Q3 10-Q 2019-10-22 0001384101-19-000132
us-gaap DeferredRevenue Deferred Revenue USD 500,000 2018-06-30 2018 Q2 10-Q 2018-07-23 0001384101-18-000060
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2016-12-31 2016 FY 10-K 2017-03-01 0001384101-17-000008
us-gaap DeferredRevenueLeasesNetNoncurrent Deferred Lease Income, after Accumulated Amortization, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-02-25 0001384101-20-000015
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 948,000 2014-12-31 2015 FY 10-K 2016-03-14 0001047469-16-011115
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -273,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 5.16M 2019-12-31 2019 FY 10-K 2020-02-25 0001384101-20-000015
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 7.02M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 228.50M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeferredTaxAssetsGrossCurrent Deferred Tax Assets, Gross, Current USD 2.61M 2014-12-31 2014 FY 10-K 2015-03-25 0001047469-15-002671
us-gaap DeferredTaxAssetsGrossNoncurrent Deferred Tax Assets, Gross, Noncurrent USD 70.39M 2019-12-31 2019 FY 10-K 2020-02-25 0001384101-20-000015
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2020-12-31 2020 FY 10-K 2021-02-22 0001384101-21-000012
us-gaap DeferredTaxAssetsLiabilitiesNetCurrent Deferred Tax Assets, Net, Current USD 300,000 2014-12-31 2015 FY 10-K 2016-03-14 0001047469-16-011115
us-gaap DeferredTaxAssetsLiabilitiesNetNoncurrent Deferred Tax Assets, Net, Noncurrent USD -6.51M 2015-12-31 2015 FY 10-K 2016-03-14 0001047469-16-011115
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 31.20M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 300,000 2014-12-31 2014 FY 10-K 2015-03-25 0001047469-15-002671
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 4.00M 2017-12-31 2017 FY 10-K 2018-02-27 0001384101-18-000006
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 158.19M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 18.61M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.97M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeferredTaxAssetsValuationAllowanceCurrent Deferred Tax Assets, Valuation Allowance, Current USD 2.31M 2014-12-31 2014 FY 10-K 2015-03-25 0001047469-15-002671
us-gaap DeferredTaxAssetsValuationAllowanceNoncurrent Deferred Tax Assets, Valuation Allowance, Noncurrent USD 51.66M 2017-12-31 2017 FY 10-K 2018-02-27 0001384101-18-000006
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 646,000 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 1.55M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 20.08M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DeferredTaxLiabilitiesGrossNoncurrent Deferred Tax Liabilities, Gross, Noncurrent USD 4.00M 2017-12-31 2017 FY 10-K 2018-02-27 0001384101-18-000006
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 300,000 2014-12-31 2015 FY 10-K 2016-03-14 0001047469-16-011115
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 1.08M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DefinedBenefitPlanBenefitObligation Defined Benefit Plan, Benefit Obligation USD 500,000 2025-06-30 2025 Q2 10-Q 2025-08-07 0001384101-25-000110
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 613,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001384101-21-000012
us-gaap Depreciation Depreciation USD 8.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 16.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 583,000 2012-12-31 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-02 0001437749-20-022261
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 1.07 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.66 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001384101-21-000082
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 1.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.104 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount USD -24,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD -5.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure -0.082 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.078 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.016 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 628,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-25 0001384101-20-000015
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0.032 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.067 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.067 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -102,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 29.81M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 60.90M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueAmount Equity Securities without Readily Determinable Fair Value, Amount USD 1.00M 2020-07-31 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount USD 3.32M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount USD 0 2020-09-30 2020 Q3 10-Q 2020-11-02 0001437749-20-022261
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 300,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 86,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001047469-16-011115
us-gaap FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) USD -2.07M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001047469-16-011115
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD -2.07M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-25 0001104659-13-086891
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 2.65M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-25 0001104659-13-086891
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 252,000 2013-09-30 2013 Q3 10-Q 2013-11-25 0001104659-13-086891
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs USD -583,000 2012-12-31 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 257,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001047469-16-011115
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001384101-21-000012
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 100,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0001384101-24-000162
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 79,000 2019-09-30 2019 Q3 10-Q 2019-10-22 0001384101-19-000132
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 874,000 2016-12-31 2019 Q3 10-Q 2019-10-22 0001384101-19-000132
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 79,000 2019-09-30 2019 Q3 10-Q 2019-10-22 0001384101-19-000132
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001384101-22-000028
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 100,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0001384101-24-000162
us-gaap FinanceLeaseRightOfUseAssetAccumulatedAmortization Finance Lease, Right-of-Use Asset, Accumulated Amortization USD 600,000 2019-12-31 2020 FY 10-K 2021-02-22 0001384101-21-000012
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 233,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-22 0001384101-21-000012
us-gaap FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization Finance Lease, Right-of-Use Asset, before Accumulated Amortization USD 1.20M 2019-12-31 2020 FY 10-K 2021-02-22 0001384101-21-000012
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 73.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 21.02M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 22.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 5.63M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 11.71M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 18.72M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 21.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 22.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 258.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 184.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 23,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -367,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 80.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap Goodwill Goodwill USD 855.58M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 88.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD -13.16M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001384101-25-000014
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap GrossProfit Gross Profit USD 316.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss USD 63,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap HeldToMaturitySecuritiesFairValue Debt Securities, Held-to-maturity, Fair Value USD 170.64M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap HeldtomaturitySecuritiesSoldAtPar Debt Securities, Held-to-maturity, Sold at Par Value USD 40.00M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap HeldtomaturitySecuritiesSoldSecurityRealizedGainLossExcludingOtherThanTemporaryImpairments Debt Securities, Held-to-maturity, Sold, Realized Gain (Loss), Excluding Other-than-temporary Impairment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 20.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 95.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 77.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -27.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -54.85M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-07-29 0001384101-21-000139
us-gaap IncomeTaxesPaid Income Taxes Paid USD 2.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 3.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -8.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 169,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 3.47M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 76.73M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Amount USD 74.72M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 3.94M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 14.32M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 5.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 155,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -469,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 801,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 2.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 4.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 4.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 5.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 11.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -3.30M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-02 0001437749-20-022261
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 10.00M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-25 0001047469-15-002671
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 2.86M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap IncreaseDecreaseInMaterialsAndSupplies Increase (Decrease) in Materials and Supplies USD 3.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 496,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 771,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 4.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD -120,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001384101-18-000006
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 2.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 6.20M 2025-09-30 2025 Q3 10-Q 2025-11-05 0001384101-25-000130
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 258.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 184.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap InterestExpense Interest Expense USD 116,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-07-29 0001384101-21-000139
us-gaap InterestExpenseDebt Interest Expense, Debt USD 229,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001384101-21-000012
us-gaap InterestExpenseDebtExcludingAmortization Interest Expense, Debt, Excluding Amortization USD 13,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001384101-21-000012
us-gaap InterestExpenseLesseeAssetsUnderCapitalLease Interest Expense, Lessee, Assets under Capital Lease USD 26,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 741,000 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-07-23 0001384101-18-000060
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001384101-25-000014
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap InventoryNet Inventory, Net USD 20.55M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap InventoryRawMaterialsAndSupplies Inventory, Raw Materials and Supplies, Gross USD 25.82M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap InventoryWorkInProcessAndRawMaterials Inventory, Work in Process and Raw Materials USD 3.90M 2024-12-31 2024 FY 10-K 2025-02-28 0001384101-25-000014
us-gaap InventoryWriteDown Inventory Write-down USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 5,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.075 2020-12-31 2020 FY 10-K 2021-02-22 0001384101-21-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 70.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 40.41M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 7.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 7.05M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 7.05M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 6.86M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 7.39M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.71M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 30.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap Liabilities Liabilities USD 139.99M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.57B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap LiabilitiesCurrent Liabilities, Current USD 84.21M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap LitigationSettlementAmountAwardedFromOtherParty Litigation Settlement, Amount Awarded from Other Party USD 400,000 2018-03-01 2018-03-31 2019 Q3 10-Q 2019-10-22 0001384101-19-000132
us-gaap LoansReceivableFairValueDisclosure Loans Receivable, Fair Value Disclosure USD 1.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2022-12-31 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0001384101-22-000028
us-gaap LossContingencyPatentsAllegedlyInfringedNumber Loss Contingency, Patents Allegedly Infringed, Number patent 2 2025-06-04 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD -25.33M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001384101-18-000006
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -2.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 901,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-01 0001384101-18-000026
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -280.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -227,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-01 0001384101-18-000026
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 121.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -7.41M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-01 0001384101-18-000026
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 85.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 85.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 85.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 6.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap NotesIssued1 Notes Issued USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001384101-17-000008
us-gaap NotesReduction Notes Reduction USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-01 0001384101-17-000008
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OperatingExpenses Operating Expenses USD 114.24M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 62.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 5.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 40.74M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 6.81M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 33.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 35.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 18.82M 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.23M 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 2.54M 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 2.47M 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 2.40M 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 2.33M 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 6.84M 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 516,000 2018-09-30 2018 Q3 10-Q 2018-10-29 0001384101-18-000078
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 1.40M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-10-22 0001384101-19-000132
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.114 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 30.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 3.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD 151,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 24.13M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001384101-25-000110
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 151,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OtherInventorySupplies Other Inventory, Supplies, Gross USD 20.55M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 3.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 15.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001384101-21-000012
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 38.70M 2021-02-01 2021-02-28 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 17.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001384101-21-000012
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 153.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap PaymentsToAcquireBusinessThreeNetOfCashAcquired Payments to Acquire Business Three, Net of Cash Acquired USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001384101-22-000028
us-gaap PaymentsToAcquireBusinessTwoNetOfCashAcquired Payments to Acquire Business Two, Net of Cash Acquired USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001384101-24-000017
us-gaap PaymentsToAcquireHeldToMaturitySecurities Payments to Acquire Held-to-maturity Securities USD 235.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap PaymentsToAcquireInterestInSubsidiariesAndAffiliates Payments to Acquire Interest in Subsidiaries and Affiliates USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap PaymentsToAcquireLoansReceivable Payments to Acquire Loans Receivable USD 1.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap PaymentsToAcquireLongtermInvestments Payments to Acquire Long-term Investments USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001384101-22-000028
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 8.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 14.74M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap PriorPeriodReclassificationAdjustment Prior Period Reclassification Adjustment USD 212,000 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-06 0001384101-20-000058
us-gaap ProceedsFromDivestitureOfBusinessesNetOfCashDivested Proceeds from Divestiture of Businesses, Net of Cash Divested USD 2.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates Proceeds from Divestiture of Interest in Subsidiaries and Affiliates USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001384101-24-000017
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001384101-24-000017
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 193.83M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-02 0001437749-20-022261
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-25 0001384101-20-000015
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001384101-18-000006
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 12.95M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001047469-16-011115
us-gaap ProceedsFromLegalSettlements Proceeds from Legal Settlements USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-25 0001384101-20-000015
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities USD 116.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities Proceeds from Sale and Maturity of Held-to-maturity Securities USD 12.68M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap ProceedsFromSaleOfHeldToMaturitySecurities Proceeds from Sale of Held-to-maturity Securities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001384101-22-000028
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 14.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization USD 43.48M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization USD 24.87M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization USD 65.67M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 43.68M 2022-12-31 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 17.70M 2022-12-31 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap PurchaseObligation Purchase Obligation USD 44.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 64,000 2014-09-30 2014 Q3 10-Q 2014-11-13 0001104659-14-080432
us-gaap PurchaseObligationDueInSecondYear Purchase Obligation, to be Paid, Year Two USD 125,000 2013-12-31 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap RecognitionOfDeferredRevenue Recognition of Deferred Revenue USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001384101-18-000006
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 308,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-25 0001384101-20-000015
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001384101-25-000014
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 88.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap RestrictedCash Restricted Cash USD 1.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 1.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 0 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 1.64M 2025-09-30 2025 Q3 10-Q 2025-11-05 0001384101-25-000130
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 1.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -291.93M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 441.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 250,000 2018-06-30 2018 Q2 10-Q 2018-07-23 0001384101-18-000060
us-gaap Revenues Revenues USD 66.26M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-10-29 0001384101-18-000078
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 33.20M 2024-10-01 2024-12-31 2024 FY 10-K 2025-02-28 0001384101-25-000014
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 14.12M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-25 0001384101-20-000015
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 593.80M 2021-02-01 2021-02-28 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 8.55M 2021-02-01 2021-02-28 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 30 2020-08-07 2020 Q3 10-Q 2020-11-02 0001437749-20-022261
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 42.79M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-07-23 0001384101-18-000060
us-gaap SecurityDeposit Security Deposit USD 1.60M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 84.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 40.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 24.37 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 2.84M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0001384101-23-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.57M 2018-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 24.68M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.51M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 26.86 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 11.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 472,983 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 14.9 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 28.89M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 4.81M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 26.41 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 28.58M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 1.72M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 26.44 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 5.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 7.01 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001047469-16-011115
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 18.66 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 10.59 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 6.15 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-03 0001628280-16-020770
us-gaap SharePrice Share Price USD/shares 7.61 2016-09-30 2016 Q3 10-Q 2016-11-03 0001628280-16-020770
us-gaap ShortTermInvestments Short-term Investments USD 50.31M 2025-12-31 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.43B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 4 2013-10-08 2013-10-09 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap StockIssued1 Stock Issued USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001384101-24-000017
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 15.00M 2013-11-02 2013-11-04 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 6.90M 2020-08-07 2020 Q3 10-Q 2020-11-02 0001437749-20-022261
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 591,008 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 74.14M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 79.02M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001047469-16-011115
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 3.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 193.83M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-02 0001437749-20-022261
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 8.07M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-02 0001437749-20-022261
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 538,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-25 0001384101-19-000010
us-gaap TaxCreditCarryforwardValuationAllowance Tax Credit Carryforward, Valuation Allowance USD 197.30M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 63.37M 2012-12-31 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2013-12-31 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2013-12-31 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap TemporaryEquityRedemptionValue Temporary Equity, Redemption Value (Deprecated 2014-01-31) USD 79.02M 2013-09-30 2013 Q3 10-Q 2013-11-25 0001104659-13-086891
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2013-12-31 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2013-12-31 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2013-12-31 2013 FY 10-K 2014-03-20 0001047469-14-002734
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 9.55M 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 45,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.65M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 774,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -30.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001384101-26-000010
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 82.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 63.33M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001384101-21-000082
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 80.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001384101-26-000055

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →